AAAAAA

   
Results: 1-8 |
Results: 8
IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY
Authors: MIGNOTTE H LASSET C BONADONA V LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C PARACHE RM CHAUVIN F
Citation: H. Mignotte et al., IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY, International journal of cancer, 76(3), 1998, pp. 325-330
ENDOMETRIAL CARCINOMA (EC) IN WOMEN WITH BREAST-CANCER (BC)
Authors: MIGNOTTE H LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C LASSET C BONADONA V CHAUVIN F
Citation: H. Mignotte et al., ENDOMETRIAL CARCINOMA (EC) IN WOMEN WITH BREAST-CANCER (BC), European journal of cancer, 33, 1997, pp. 925-925
PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/
Authors: CAPPELAERE P FOURNIER C ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F PION JM HECQUET B
Citation: P. Cappelaere et al., PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/, Bulletin du cancer, 83(7), 1996, pp. 559-565
THERAPEUTIC MONITORING OF 120 HOURS CONTI NUOUS 5-FLUOROURACIL ASSOCIATED WITH CISPLATIN
Authors: COUDERT B DEGISLAIN C BELTRAMO JL GUIGUES B MAYER F BRUCHON Y RIEDINGER JM FARGEOT P DUMAS M GUERRIN J
Citation: B. Coudert et al., THERAPEUTIC MONITORING OF 120 HOURS CONTI NUOUS 5-FLUOROURACIL ASSOCIATED WITH CISPLATIN, Bulletin du cancer, 83(10), 1996, pp. 847-852
FEASIBILITY OF 5-FU THERAPEUTIC MONITORING
Authors: COUDERT B DEGISLAIN C",BELTRAMO,"RIEDINGER JM MAYER F BRUCHON FY DUMAS M FARGEOT P GUERRIN J
Citation: B. Coudert et al., FEASIBILITY OF 5-FU THERAPEUTIC MONITORING, European journal of cancer, 31A, 1995, pp. 966-966
DUCTAL CARCINOMA IN-SITU (DCIS) OF THE MALE BREAST - ANALYSIS OF 23 CASES
Authors: CUTULI B VELTEN M LACROZE M CAMPANA F DILHUYDY JM MARCHAL C DELAFONTAN B RESBEUT M GRAIC Y TORTOCHEAUX J DEGISLAIN C MONCHO V CUILLERE JC NGUYEN TD HERY M LESIMPLE T REMESAUMON M LESAUNIER F GAMELIN E BERLIE J
Citation: B. Cutuli et al., DUCTAL CARCINOMA IN-SITU (DCIS) OF THE MALE BREAST - ANALYSIS OF 23 CASES, European journal of cancer, 31A, 1995, pp. 1021-1021
MALE BREAST-CANCER - RESULTS OF THE TREATMENTS AND PROGNOSTIC FACTORSIN 397 CASES
Authors: CUTULI B LACROZE M DILHUYDY JM VELTEN M DELAFONTAN B MARCHAL C RESBEUT M GRAIC Y CAMPANA F MONCHOBERNIER V DEGISLAIN C TORTOCHAUX J CUILLERE JC REMESAUMON M NGUYEN TD LESAUNIER F LESIMPLE T GAMELIN E HERY M BERLIE J
Citation: B. Cutuli et al., MALE BREAST-CANCER - RESULTS OF THE TREATMENTS AND PROGNOSTIC FACTORSIN 397 CASES, European journal of cancer, 31A(12), 1995, pp. 1960-1964
RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE
Authors: CAPPELAERE P HECQUET B ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F CARDE P
Citation: P. Cappelaere et al., RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE, Bulletin du cancer, 82(9), 1995, pp. 732-737
Risultati: 1-8 |